Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Sep;59(9):672–683. doi: 10.1136/ard.59.9.672

Pathogenesis of human parvovirus B19 in rheumatic disease

J Kerr 1
PMCID: PMC1753262  PMID: 10976079

Full Text

The Full Text of this article is available as a PDF (164.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasted B., Tierney G. S., Bloom M. E. Analysis of the quantity of antiviral antibodies from mink infected with different Aleutian disease virus strains. Scand J Immunol. 1984 May;19(5):395–402. doi: 10.1111/j.1365-3083.1984.tb00947.x. [DOI] [PubMed] [Google Scholar]
  2. Ager E. A., Chin T. D., Poland J. D. Epidemic erythema infectiosum. N Engl J Med. 1966 Dec 15;275(24):1326–1331. doi: 10.1056/NEJM196612152752402. [DOI] [PubMed] [Google Scholar]
  3. Alexandersen S., Bloom M. E., Wolfinbarger J. Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol. 1988 May;62(5):1495–1507. doi: 10.1128/jvi.62.5.1495-1507.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Altschuler E. L. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning. Lancet. 1999 Sep 18;354(9183):1026–1027. doi: 10.1016/S0140-6736(98)12312-7. [DOI] [PubMed] [Google Scholar]
  5. Amiot L., Langanay T., Drénou B., Lelong B., Le Prisé P. Y., Logeais Y., Colimon R., Fauchet R. Spontaneous recovery from severe parvovirus B19 pure red cell aplasia, in a heart transplant recipient, as demonstrated by marrow culture. Hematol Cell Ther. 1998 Apr;40(2):71–73. [PubMed] [Google Scholar]
  6. Anderson L. J., Tsou C., Parker R. A., Chorba T. L., Wulff H., Tattersall P., Mortimer P. P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986 Oct;24(4):522–526. doi: 10.1128/jcm.24.4.522-526.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Anderson M. J., Davis L. R., Hodgson J., Jones S. E., Murtaza L., Pattison J. R., Stroud C. E., White J. M. Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol. 1982 Jul;35(7):744–749. doi: 10.1136/jcp.35.7.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Anderson M. J., Higgins P. G., Davis L. R., Willman J. S., Jones S. E., Kidd I. M., Pattison J. R., Tyrrell D. A. Experimental parvoviral infection in humans. J Infect Dis. 1985 Aug;152(2):257–265. doi: 10.1093/infdis/152.2.257. [DOI] [PubMed] [Google Scholar]
  9. Anderson M. J., Lewis E., Kidd I. M., Hall S. M., Cohen B. J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984 Aug;93(1):85–93. doi: 10.1017/s0022172400060964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Andrès E., Grunenberger F., Schlienger J. L., Imler M. Vascularite cutanée révélatrice d'une infection à parvovirus B19. Ann Med Interne (Paris) 1997;148(1):107–108. [PubMed] [Google Scholar]
  11. Bagot M., Revuz J. Papular-purpuric "gloves and socks" syndrome: primary infection with parvovirus B19? J Am Acad Dermatol. 1991 Aug;25(2 Pt 1):341–342. doi: 10.1016/s0190-9622(08)80483-5. [DOI] [PubMed] [Google Scholar]
  12. Balfour H. H., Jr Erythema infectiosum (fifth disease). Clinical review and description of 91 cases seen in an epidemic. Clin Pediatr (Phila) 1969 Dec;8(12):721–727. doi: 10.1177/000992286900801212. [DOI] [PubMed] [Google Scholar]
  13. Balfour H. H., Jr, Schiff G. M., Bloom J. E. Encephalitis associated with erythema infectiosum. J Pediatr. 1970 Jul;77(1):133–136. doi: 10.1016/s0022-3476(70)80059-2. [DOI] [PubMed] [Google Scholar]
  14. Balkaran B., Char G., Morris J. S., Thomas P. W., Serjeant B. E., Serjeant G. R. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992 Mar;120(3):360–366. doi: 10.1016/s0022-3476(05)80897-2. [DOI] [PubMed] [Google Scholar]
  15. Bateman H. E., Kirou K. A., Paget S. A., Crow M. K., Yee A. M. Remission of juvenile rheumatoid arthritis after infection with parvovirus B19. J Rheumatol. 1999 Nov;26(11):2482–2484. [PubMed] [Google Scholar]
  16. Bengtsson A., Widell A., Elmstâhl S., Sturfelt G. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis. 2000 Jan;59(1):64–66. doi: 10.1136/ard.59.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Berg A. M., Naides S. J., Simms R. W. Established fibromyalgia syndrome and parvovirus B19 infection. J Rheumatol. 1993 Nov;20(11):1941–1943. [PubMed] [Google Scholar]
  18. Bertoni E., Rosati A., Zanazzi M., Azzi A., Zakrewska K., Guidi S., Salvadori M. Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients. Transplant Proc. 1997 Feb-Mar;29(1-2):818–819. doi: 10.1016/s0041-1345(96)00147-9. [DOI] [PubMed] [Google Scholar]
  19. Bertrand Y., Lefrere J. J., Leverger G., Courouce A. M., Feo C., Clark M., Schaison G., Soulier J. P. Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastopenia. Lancet. 1985 Aug 17;2(8451):382–383. doi: 10.1016/s0140-6736(85)92509-7. [DOI] [PubMed] [Google Scholar]
  20. Blidi M., Gatfosse M., Barjonet G. Maladie de Still de l'adulte associée à une infection aiguë par le parvovirus B 19, survenant au cours d'une grossesse. Ann Med Interne (Paris) 1996;147(7):518–519. [PubMed] [Google Scholar]
  21. Bloom M. E., Alexandersen S., Mori S., Wolfinbarger J. B. Analysis of parvovirus infections using strand-specific hybridization probes. Virus Res. 1989 Sep;14(1):1–25. doi: 10.1016/0168-1702(89)90066-x. [DOI] [PubMed] [Google Scholar]
  22. Blundell M. C., Beard C., Astell C. R. In vitro identification of a B19 parvovirus promoter. Virology. 1987 Apr;157(2):534–538. doi: 10.1016/0042-6822(87)90296-0. [DOI] [PubMed] [Google Scholar]
  23. Borreda D., Palomera S., Gilbert B., Lienhardt A., de Lumley L. A propos de vingt-quatre observations d'infections à parvovirus humain B19 chez l'enfant. Ann Pediatr (Paris) 1992 Nov;39(9):543–549. [PubMed] [Google Scholar]
  24. Bousvaros A., Sundel R., Thorne G. M., McIntosh K., Cohen M., Erdman D. D., Perez-Atayde A., Finkel T. H., Colin A. A. Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis. Pediatr Pulmonol. 1998 Nov;26(5):365–369. doi: 10.1002/(sici)1099-0496(199811)26:5<365::aid-ppul11>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  25. Brass C., Elliott L. M., Stevens D. A. Academy rash. A probable epidemic of erythema infectiosum ('fifth disease'). JAMA. 1982 Aug 6;248(5):568–572. doi: 10.1001/jama.248.5.568. [DOI] [PubMed] [Google Scholar]
  26. Breese C., Horner F. A. Encephalopathy with erythema infectiosum. Am J Dis Child. 1977 Jan;131(1):65–67. [PubMed] [Google Scholar]
  27. Brown K. E., Anderson S. M., Young N. S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993 Oct 1;262(5130):114–117. doi: 10.1126/science.8211117. [DOI] [PubMed] [Google Scholar]
  28. Brown K. E., Green S. W., Antunez de Mayolo J., Bellanti J. A., Smith S. D., Smith T. J., Young N. S. Congenital anaemia after transplacental B19 parvovirus infection. Lancet. 1994 Apr 9;343(8902):895–896. doi: 10.1016/s0140-6736(94)90011-6. [DOI] [PubMed] [Google Scholar]
  29. Brown K. E., Hibbs J. R., Gallinella G., Anderson S. M., Lehman E. D., McCarthy P., Young N. S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med. 1994 Apr 28;330(17):1192–1196. doi: 10.1056/NEJM199404283301704. [DOI] [PubMed] [Google Scholar]
  30. Brown K. E., Mori J., Cohen B. J., Field A. M. In vitro propagation of parvovirus B19 in primary foetal liver culture. J Gen Virol. 1991 Mar;72(Pt 3):741–745. doi: 10.1099/0022-1317-72-3-741. [DOI] [PubMed] [Google Scholar]
  31. Brown T., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984 Nov 3;2(8410):1033–1034. doi: 10.1016/s0140-6736(84)91126-7. [DOI] [PubMed] [Google Scholar]
  32. Cassinotti P., Schultze D., Schlageter P., Chevili S., Siegl G. Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis. 1993 Sep;12(9):701–704. doi: 10.1007/BF02009384. [DOI] [PubMed] [Google Scholar]
  33. Chakravarty K., Merry P. Systemic vasculitis and atypical infections: report of two cases. Postgrad Med J. 1999 Sep;75(887):544–546. doi: 10.1136/pgmj.75.887.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Chao C. C., Janoff E. N., Hu S. X., Thomas K., Gallagher M., Tsang M., Peterson P. K. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine. 1991 Jul;3(4):292–298. doi: 10.1016/1043-4666(91)90497-2. [DOI] [PubMed] [Google Scholar]
  35. Chassagne P., Mejjad O., Gourmelen O., Moore N., Le Loet X., Deshayes P. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection. Br J Rheumatol. 1993 Feb;32(2):158–159. doi: 10.1093/rheumatology/32.2.158. [DOI] [PubMed] [Google Scholar]
  36. Chorba T., Anderson L. J. Erythema infectiosum (fifth disease). Clin Dermatol. 1989 Jan-Mar;7(1):65–74. doi: 10.1016/0738-081x(89)90030-8. [DOI] [PubMed] [Google Scholar]
  37. Christensen J., Cotmore S. F., Tattersall P. Two new members of the emerging KDWK family of combinatorial transcription modulators bind as a heterodimer to flexibly spaced PuCGPy half-sites. Mol Cell Biol. 1999 Nov;19(11):7741–7750. doi: 10.1128/mcb.19.11.7741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chundu K. R., Lal S., Bartley D. L. Multiple organ dysfunction caused by parvovirus B19. West J Med. 1995 Dec;163(6):574–576. [PMC free article] [PubMed] [Google Scholar]
  39. Cohen B. J., Buckley M. M., Clewley J. P., Jones V. E., Puttick A. H., Jacoby R. K. Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis. 1986 Oct;45(10):832–838. doi: 10.1136/ard.45.10.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Cooling L. L., Koerner T. A., Naides S. J. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis. 1995 Nov;172(5):1198–1205. doi: 10.1093/infdis/172.5.1198. [DOI] [PubMed] [Google Scholar]
  41. Cope A. P., Jones A., Brozovic M., Shafi M. S., Maini R. N. Possible induction of systemic lupus erythematosus by human parvovirus. Ann Rheum Dis. 1992 Jun;51(6):803–804. doi: 10.1136/ard.51.6.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Corman L. C., Dolson D. J. Polyarteritis nodosa and parvovirus B19 infection. Lancet. 1992 Feb 22;339(8791):491–491. doi: 10.1016/0140-6736(92)91096-q. [DOI] [PubMed] [Google Scholar]
  43. Corman L. C., Staud R. Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al. Arthritis Rheum. 1995 Aug;38(8):1174–1175. doi: 10.1002/art.1780380826. [DOI] [PubMed] [Google Scholar]
  44. Corridan P. G., Laws D. E., Morrell A. J., Murray P. I. Tonic pupils and human parvovirus (B19) infection. J Clin Neuroophthalmol. 1991 Jun;11(2):109–110. [PubMed] [Google Scholar]
  45. Cossart Y. E., Field A. M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72–73. doi: 10.1016/s0140-6736(75)91074-0. [DOI] [PubMed] [Google Scholar]
  46. Cotmore S. F., McKie V. C., Anderson L. J., Astell C. R., Tattersall P. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol. 1986 Nov;60(2):548–557. doi: 10.1128/jvi.60.2.548-557.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Cotmore S. F., Tattersall P. A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles. J Virol. 1989 Sep;63(9):3902–3911. doi: 10.1128/jvi.63.9.3902-3911.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Currie J. M., Adamson D. J., Brown T., Dawson A. A. The fifth cause of splenomegaly?--Parvovirus B19. Clin Lab Haematol. 1992;14(4):327–330. doi: 10.1111/j.1365-2257.1992.tb00108.x. [DOI] [PubMed] [Google Scholar]
  49. De Boer J. H., De Keizer R. J., Kijlstra A. In search of intraocular antibody production to parvo B19 virus and adenovirus in intermediate uveitis. Br J Ophthalmol. 1993 Dec;77(12):829–829. doi: 10.1136/bjo.77.12.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Deiss V., Tratschin J. D., Weitz M., Siegl G. Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini. Virology. 1990 Mar;175(1):247–254. doi: 10.1016/0042-6822(90)90205-6. [DOI] [PubMed] [Google Scholar]
  51. Denning D. W., Amos A., Rudge P., Cohen B. J. Neuralgic amyotrophy due to parvovirus infection. J Neurol Neurosurg Psychiatry. 1987 May;50(5):641–642. doi: 10.1136/jnnp.50.5.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Dereure O., Montes B., Guilhou J. J. Acute generalized livedo reticularis with myasthenialike syndrome revealing parvovirus B19 primary infection. Arch Dermatol. 1995 Jun;131(6):744–745. [PubMed] [Google Scholar]
  53. Dijkmans B. A., van Elsacker-Niele A. M., Salimans M. M., van Albada-Kuipers G. A., de Vries E., Weiland H. T. Human parvovirus B19 DNA in synovial fluid. Arthritis Rheum. 1988 Feb;31(2):279–281. doi: 10.1002/art.1780310218. [DOI] [PubMed] [Google Scholar]
  54. Dinerman J. L., Corman L. C. Human parvovirus B19 arthropathy associated with desquamation. Am J Med. 1990 Dec;89(6):826–828. doi: 10.1016/0002-9343(90)90235-6. [DOI] [PubMed] [Google Scholar]
  55. Diss T. C., Pan L. X., Du M. Q., Peng H. Z., Kerr J. R. Parvovirus B19 is associated with benign testes as well as testicular germ cell tumours. Mol Pathol. 1999 Dec;52(6):349–352. doi: 10.1136/mp.52.6.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Duncan J. R., Potter C. B., Cappellini M. D., Kurtz J. B., Anderson M. J., Weatherall D. J. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet. 1983 Jul 2;2(8340):14–16. doi: 10.1016/s0140-6736(83)90005-3. [DOI] [PubMed] [Google Scholar]
  57. Dÿkmans B. A., Breedveld F. C., de Vries R. R. HLA antigens in human parvovirus arthropathy. J Rheumatol. 1986 Dec;13(6):1192–1193. [PubMed] [Google Scholar]
  58. Erdman D. D., Usher M. J., Tsou C., Caul E. O., Gary G. W., Kajigaya S., Young N. S., Anderson L. J. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol. 1991 Oct;35(2):110–115. doi: 10.1002/jmv.1890350207. [DOI] [PubMed] [Google Scholar]
  59. Faden H., Gary G. W., Jr, Korman M. Numbness and tingling of fingers associated with parvovirus B19 infection. J Infect Dis. 1990 Feb;161(2):354–355. doi: 10.1093/infdis/161.2.354. [DOI] [PubMed] [Google Scholar]
  60. Ferri C., Zakrzewska K., Longombardo G., Giuggioli D., Storino F. A., Pasero G., Azzi A. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol. 1999 Nov-Dec;17(6):718–720. [PubMed] [Google Scholar]
  61. Finkel T. H., Török T. J., Ferguson P. J., Durigon E. L., Zaki S. R., Leung D. Y., Harbeck R. J., Gelfand E. W., Saulsbury F. T., Hollister J. R. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet. 1994 May 21;343(8908):1255–1258. doi: 10.1016/s0140-6736(94)92152-0. [DOI] [PubMed] [Google Scholar]
  62. Frickhofen N., Abkowitz J. L., Safford M., Berry J. M., Antunez-de-Mayolo J., Astrow A., Cohen R., Halperin I., King L., Mintzer D. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med. 1990 Dec 15;113(12):926–933. doi: 10.7326/0003-4819-113-12-926. [DOI] [PubMed] [Google Scholar]
  63. Fukuda K., Straus S. E., Hickie I., Sharpe M. C., Dobbins J. G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953–959. doi: 10.7326/0003-4819-121-12-199412150-00009. [DOI] [PubMed] [Google Scholar]
  64. Gabriel S. E., Espy M., Erdman D. D., Bjornsson J., Smith T. F., Hunder G. G. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum. 1999 Jun;42(6):1255–1258. doi: 10.1002/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  65. Gahr M., Pekrun A., Eiffert H. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Pediatr. 1991 May;150(7):470–472. doi: 10.1007/BF01958424. [DOI] [PubMed] [Google Scholar]
  66. García-Tapia A. M., Martínez-Rodríguez A., Fernández-Gutiérrez C., Mira J., Lechuga J. L. Eritema multiforme ampolloso por parvovirus humano B19. Enferm Infecc Microbiol Clin. 1993 Dec;11(10):575–576. [PubMed] [Google Scholar]
  67. Gautier E., Bourhis J. H., Bayle C., Cartron J., Pico J. L., Tchernia G. Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF. Hematol Cell Ther. 1997 Apr;39(2):85–87. doi: 10.1007/s00282-997-0085-5. [DOI] [PubMed] [Google Scholar]
  68. Gendi N. S., Gibson K., Wordsworth B. P. Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak. Ann Rheum Dis. 1996 Jan;55(1):63–65. doi: 10.1136/ard.55.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Generini S., Fiori G., Moggi Pignone A., Matucci Cerinic M., Cagnoni M. Systemic sclerosis. A clinical overview. Adv Exp Med Biol. 1999;455:73–83. [PubMed] [Google Scholar]
  70. Gilsanz F., Garcia Vela J., Vargas J. A., Ibañez J., Oña F., López J., Roggendorf M. Acquired pure red cell aplasia: a study of six cases. Ann Hematol. 1995 Oct;71(4):181–183. doi: 10.1007/BF01910315. [DOI] [PubMed] [Google Scholar]
  71. Goldman F., Rotbart H., Gutierrez K., Ambruso D. Parvovirus-associated aplastic crisis in a patient with red blood cell glucose-6-phosphate dehydrogenase deficiency. Pediatr Infect Dis J. 1990 Aug;9(8):593–594. [PubMed] [Google Scholar]
  72. Graeve J. L., de Alarcon P. A., Naides S. J. Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol. 1989 Winter;11(4):441–444. [PubMed] [Google Scholar]
  73. Gran J. T., Johnsen V., Myklebust G., Nordbø S. A. The variable clinical picture of arthritis induced by human parvovirus B19. Report of seven adult cases and review of the literature. Scand J Rheumatol. 1995;24(3):174–179. doi: 10.3109/03009749509099309. [DOI] [PubMed] [Google Scholar]
  74. Gratacós E., Torres P. J., Vidal J., Antolín E., Costa J., Jiménez de Anta M. T., Cararach V., Alonso P. L., Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis. 1995 May;171(5):1360–1363. doi: 10.1093/infdis/171.5.1360. [DOI] [PubMed] [Google Scholar]
  75. Gray E. S., Davidson R. J., Anand A. Human parvovirus and fetal anaemia. Lancet. 1987 May 16;1(8542):1144–1144. doi: 10.1016/s0140-6736(87)91699-0. [DOI] [PubMed] [Google Scholar]
  76. Green J. E., Hinrichs S. H., Vogel J., Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature. 1989 Sep 7;341(6237):72–74. doi: 10.1038/341072a0. [DOI] [PubMed] [Google Scholar]
  77. Hajeer A. H., MacGregor A. J., Rigby A. S., Ollier W. E., Carthy D., Silman A. J. Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: an analysis of disease discordant twin pairs. Ann Rheum Dis. 1994 Feb;53(2):137–139. doi: 10.1136/ard.53.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Halasz C. L., Cormier D., Den M. Petechial glove and sock syndrome caused by parvovirus B19. J Am Acad Dermatol. 1992 Nov;27(5 Pt 2):835–838. doi: 10.1016/0190-9622(92)70260-m. [DOI] [PubMed] [Google Scholar]
  79. Hall W. W. Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma. J Exp Med. 1994 Nov 1;180(5):1581–1585. doi: 10.1084/jem.180.5.1581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Harrison B., Silman A., Barrett E., Symmons D. Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis. Ann Rheum Dis. 1998 Jun;57(6):375–377. doi: 10.1136/ard.57.6.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Hemauer A., Beckenlehner K., Wolf H., Lang B., Modrow S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol. 1999 Sep;14(1):73–77. doi: 10.1016/s1386-6532(99)00038-4. [DOI] [PubMed] [Google Scholar]
  82. Imbert B., Brion J. P., Janbon B., Gonzales M., Micoud M. Erythème noueux associé à une infection par le parvovirus B19. Presse Med. 1989 Oct 28;18(35):1753–1754. [PubMed] [Google Scholar]
  83. Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajima I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 1991 Aug 30;253(5023):1026–1028. doi: 10.1126/science.1887217. [DOI] [PubMed] [Google Scholar]
  84. Jacks T. A. Pruritus in parvovirus infection. J R Coll Gen Pract. 1987 May;37(298):210–211. [PMC free article] [PubMed] [Google Scholar]
  85. Jacobson S. K., Daly J. S., Thorne G. M., McIntosh K. Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history and review. Clin Infect Dis. 1997 Jun;24(6):1048–1051. doi: 10.1086/513627. [DOI] [PubMed] [Google Scholar]
  86. Jawad A. S. Persistent arthritis after human parvovirus B19 infection. Lancet. 1993 Feb 20;341(8843):494–494. doi: 10.1016/0140-6736(93)90247-e. [DOI] [PubMed] [Google Scholar]
  87. Joseph P. R. Fifth disease: the frequency of joint involvement in adults. N Y State J Med. 1986 Nov;86(11):560–563. [PubMed] [Google Scholar]
  88. Kajigaya S., Shimada T., Fujita S., Young N. S. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7601–7605. doi: 10.1073/pnas.86.19.7601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Kalish R. A., Knopf A. N., Gary G. W., Canoso J. J. Lupus-like presentation of human parvovirus B19 infection. J Rheumatol. 1992 Jan;19(1):169–171. [PubMed] [Google Scholar]
  90. Kandolf R., Kirschner P., Hofschneider P. H., Vischer T. L. Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization. Clin Rheumatol. 1989 Sep;8(3):398–401. doi: 10.1007/BF02030355. [DOI] [PubMed] [Google Scholar]
  91. Karetnyi Y. V., Beck P. R., Markin R. S., Langnas A. N., Naides S. J. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol. 1999;144(9):1713–1724. doi: 10.1007/s007050050699. [DOI] [PubMed] [Google Scholar]
  92. Kelleher J. F., Jr, Luban N. L., Cohen B. J., Mortimer P. P. Human serum parvovirus as the cause of aplastic crisis in sickle cell disease. Am J Dis Child. 1984 Apr;138(4):401–403. doi: 10.1001/archpedi.1984.02140420067020. [DOI] [PubMed] [Google Scholar]
  93. Kerr J. R., Boyd N. Autoantibodies following parvovirus B19 infection. J Infect. 1996 Jan;32(1):41–47. doi: 10.1016/s0163-4453(96)80008-9. [DOI] [PubMed] [Google Scholar]
  94. Kerr J. R., Cartron J. P., Curran M. D., Moore J. E., Elliott J. R., Mollan R. A. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol. 1995 Sep;34(9):809–813. doi: 10.1093/rheumatology/34.9.809. [DOI] [PubMed] [Google Scholar]
  95. Kerr J. R., Coyle P. V., DeLeys R. J., Patterson C. C. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection. J Med Virol. 1996 Jan;48(1):68–75. doi: 10.1002/(SICI)1096-9071(199601)48:1<68::AID-JMV11>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  96. Kerr J. R., Curran M. D., Moore J. E., Murphy P. G. Parvovirus B19 infection--persistence and genetic variation. Scand J Infect Dis. 1995;27(6):551–557. doi: 10.3109/00365549509047066. [DOI] [PubMed] [Google Scholar]
  97. Kerr J. R., Ferguson W. P., Mcmillan S. A., Bruce I. N., Bell A. L. Parvovirus B19 and acute joint swelling in rheumatoid arthritis patients. Ann Rheum Dis. 1996 Sep;55(9):648–649. doi: 10.1136/ard.55.9.648-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Kerr J. R., Kane D., Crowley B., Leonard N., O'Briain S., Coyle P. V., Mulcahy F. Parvovirus B19 infection in AIDS patients. Int J STD AIDS. 1997 Mar;8(3):184–186. doi: 10.1258/0956462971919688. [DOI] [PubMed] [Google Scholar]
  99. Kinney J. S., Anderson L. J., Farrar J., Strikas R. A., Kumar M. L., Kliegman R. M., Sever J. L., Hurwitz E. S., Sikes R. K. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis. 1988 Apr;157(4):663–667. doi: 10.1093/infdis/157.4.663. [DOI] [PubMed] [Google Scholar]
  100. Kishore J., Misra R., Gupta D., Ayyagari A. Raised IgM antibodies to parvovirus B19 in juvenile rheumatoid arthritis. Indian J Med Res. 1998 Jan;107:15–18. [PubMed] [Google Scholar]
  101. Klouda P. T., Corbin S. A., Bradley B. A., Cohen B. J., Woolf A. D. HLA and acute arthritis following human parvovirus infection. Tissue Antigens. 1986 Nov;28(5):318–319. doi: 10.1111/j.1399-0039.1986.tb00502.x. [DOI] [PubMed] [Google Scholar]
  102. Koch W. C., Massey G., Russell C. E., Adler S. P. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr. 1990 Mar;116(3):355–359. doi: 10.1016/s0022-3476(05)82820-3. [DOI] [PubMed] [Google Scholar]
  103. Komaroff A. L., Buchwald D. S. Chronic fatigue syndrome: an update. Annu Rev Med. 1998;49:1–13. doi: 10.1146/annurev.med.49.1.1. [DOI] [PubMed] [Google Scholar]
  104. Kotin R. M., Siniscalco M., Samulski R. J., Zhu X. D., Hunter L., Laughlin C. A., McLaughlin S., Muzyczka N., Rocchi M., Berns K. I. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2211–2215. doi: 10.1073/pnas.87.6.2211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Kurtzman G. J., Cohen B. J., Field A. M., Oseas R., Blaese R. M., Young N. S. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest. 1989 Oct;84(4):1114–1123. doi: 10.1172/JCI114274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Kurtzman G. J., Cohen B., Meyers P., Amunullah A., Young N. S. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet. 1988 Nov 19;2(8621):1159–1162. doi: 10.1016/s0140-6736(88)90233-4. [DOI] [PubMed] [Google Scholar]
  107. Kurtzman G. J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N. S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 1987 Jul 30;317(5):287–294. doi: 10.1056/NEJM198707303170506. [DOI] [PubMed] [Google Scholar]
  108. Lacaze T., de Prost Y., Lefrère J. J., Courouce A. M. Parvovirus B19 et cinquième maladie. Arch Fr Pediatr. 1987 Oct;44(8):619–620. [PubMed] [Google Scholar]
  109. Langnas A. N., Markin R. S., Cattral M. S., Naides S. J. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology. 1995 Dec;22(6):1661–1665. [PubMed] [Google Scholar]
  110. Lefrere J. J., Bourgeois H. Human parvovirus associated with erythroblastopenia in iron deficiency anaemia. J Clin Pathol. 1986 Nov;39(11):1277–1278. doi: 10.1136/jcp.39.11.1277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Lefrere J. J., Courouce A. M., Bigorie B., Truchaud F., Muller J. Y., Soulier J. P. Purpura vasculaire dû au parvovirus humain. Presse Med. 1985 Nov 23;14(40):2065–2065. [PubMed] [Google Scholar]
  112. Lefrere J. J., Courouce A. M., Girot R., Bertrand Y., Soulier J. P. Six cases of hereditary spherocytosis revealed by human parvovirus infection. Br J Haematol. 1986 Apr;62(4):653–658. doi: 10.1111/j.1365-2141.1986.tb04088.x. [DOI] [PubMed] [Google Scholar]
  113. Lefrere J. J., Courouce A. M., Girot R., Cornu P. Human parvovirus and thalassaemia. J Infect. 1986 Jul;13(1):45–49. doi: 10.1016/s0163-4453(86)92279-6. [DOI] [PubMed] [Google Scholar]
  114. Lefrere J. J., Girot R., Courouce A. M., Maier-Redelsperger M., Cornu P. Familial human parvovirus infection associated with anemia in siblings with heterozygous beta-thalassemia. J Infect Dis. 1986 May;153(5):977–979. doi: 10.1093/infdis/153.5.977. [DOI] [PubMed] [Google Scholar]
  115. Lefrere J. J., Meyer O., Menkes C. J., Beaulieu M. J., Couroucé A. M. Human parvovirus and rheumatoid arthritis. Lancet. 1985 Apr 27;1(8435):982–982. doi: 10.1016/s0140-6736(85)91751-9. [DOI] [PubMed] [Google Scholar]
  116. Lefrère J. J., Couroucé A. M., Soulier J. P., Cordier M. P., Guesne Girault M. C., Polonovski C., Bensman A. Henoch-Schönlein purpura and human parvovirus infection. Pediatrics. 1986 Jul;78(1):183–184. [PubMed] [Google Scholar]
  117. Lepore L., Pennesi M., Saletta S., Perticarari S., Presani G., Prodan M. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol. 1994 Sep-Oct;12(5):561–565. [PubMed] [Google Scholar]
  118. Leruez-Ville M., Laugé A., Morinet F., Guillevin L., Dény P. Polyarteritis nodosa and parvovirus B19. Lancet. 1994 Jul 23;344(8917):263–264. doi: 10.1016/s0140-6736(94)93030-9. [DOI] [PubMed] [Google Scholar]
  119. Leventhal L. J., Naides S. J., Freundlich B. Fibromyalgia and parvovirus infection. Arthritis Rheum. 1991 Oct;34(10):1319–1324. doi: 10.1002/art.1780341018. [DOI] [PubMed] [Google Scholar]
  120. Lewkonia R. M., Horne D., Dawood M. R. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis. 1995 Aug;21(2):430–432. doi: 10.1093/clinids/21.2.430. [DOI] [PubMed] [Google Scholar]
  121. Lobkowicz F., Ring J., Schwarz T. F., Roggendorf M. Erythema multiforme in a patient with acute human parvovirus B19 infection. J Am Acad Dermatol. 1989 May;20(5 Pt 1):849–850. doi: 10.1016/s0190-9622(89)80120-3. [DOI] [PubMed] [Google Scholar]
  122. Loizou S., Cazabon J. K., Walport M. J., Tait D., So A. K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 1997 Jan;40(1):103–108. doi: 10.1002/art.1780400115. [DOI] [PubMed] [Google Scholar]
  123. Longo G., Luppi M., Bertesi M., Ferrara L., Torelli G., Emilia G. Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis. 1998 Apr;26(4):994–995. doi: 10.1086/517644. [DOI] [PubMed] [Google Scholar]
  124. Lunardi C., Tiso M., Borgato L., Nanni L., Millo R., De Sandre G., Severi A. B., Puccetti A. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol. 1998 Mar;28(3):936–948. doi: 10.1002/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X. [DOI] [PubMed] [Google Scholar]
  125. Mabin D. C., Chowdhury V. Aplastic crisis caused by human parvovirus in two patients with hereditary stomatocytosis. Br J Haematol. 1990 Sep;76(1):153–154. doi: 10.1111/j.1365-2141.1990.tb07855.x. [DOI] [PubMed] [Google Scholar]
  126. Maini R., Edelsten C. Uveitis associated with parvovirus infection. Br J Ophthalmol. 1999 Dec;83(12):1403–1404. doi: 10.1136/bjo.83.12.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Mangge H., Kenzian H., Gallistl S., Neuwirth G., Liebmann P., Kaulfersch W., Beaufort F., Muntean W., Schauenstein K. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum. 1995 Feb;38(2):211–220. doi: 10.1002/art.1780380209. [DOI] [PubMed] [Google Scholar]
  128. Martinelli C., Azzi A., Buffini G., Comin C. E., Leoncini F. Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. AIDS. 1997 Dec;11(15):1891–1893. doi: 10.1097/00002030-199715000-00020. [DOI] [PubMed] [Google Scholar]
  129. Mehta J., Singhal S., Mehta B. C. Aplastic crisis and leg ulceration: two rare complications of hereditary sideroblastic anaemia. J Assoc Physicians India. 1992 Jul;40(7):466–467. [PubMed] [Google Scholar]
  130. Meyer O., Kahn M. F., Grossin M., Ribard P., Belmatoug N., Morinet F., Fournet J. C. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus. 1991 Nov;1(1):37–41. doi: 10.1177/096120339100100107. [DOI] [PubMed] [Google Scholar]
  131. Miki N. P., Chantler J. K. Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro. J Gen Virol. 1992 Jun;73(Pt 6):1559–1562. doi: 10.1099/0022-1317-73-6-1559. [DOI] [PubMed] [Google Scholar]
  132. Mimori A., Misaki Y., Hachiya T., Ito K., Kano S. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis. Rheumatol Int. 1994;14(3):87–90. doi: 10.1007/BF00300807. [DOI] [PubMed] [Google Scholar]
  133. Minohara Y., Koitabashi Y., Kato T., Nakajima N., Murakami H., Masaki H., Ishiko H. A case of Guillain-Barré syndrome associated with human parvovirus B19 infection. J Infect. 1998 May;36(3):327–328. doi: 10.1016/s0163-4453(98)94531-5. [DOI] [PubMed] [Google Scholar]
  134. Miyazawa K., Mori A., Okudaira H. IL-6 synthesis by rheumatoid synoviocytes is autonomously upregulated at the transcriptional level. J Allergy Clin Immunol. 1999 May;103(5 Pt 2):S437–S444. doi: 10.1016/s0091-6749(99)70159-4. [DOI] [PubMed] [Google Scholar]
  135. Moffatt S., Tanaka N., Tada K., Nose M., Nakamura M., Muraoka O., Hirano T., Sugamura K. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol. 1996 Dec;70(12):8485–8491. doi: 10.1128/jvi.70.12.8485-8491.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Moffatt S., Yaegashi N., Tada K., Tanaka N., Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol. 1998 Apr;72(4):3018–3028. doi: 10.1128/jvi.72.4.3018-3028.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Momoeda M., Wong S., Kawase M., Young N. S., Kajigaya S. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol. 1994 Dec;68(12):8443–8446. doi: 10.1128/jvi.68.12.8443-8446.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Morey A. L., Ferguson D. J., Fleming K. A. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis. J Pathol. 1993 Feb;169(2):213–220. doi: 10.1002/path.1711690207. [DOI] [PubMed] [Google Scholar]
  139. Morey A. L., Keeling J. W., Porter H. J., Fleming K. A. Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol. 1992 Jul;99(7):566–574. doi: 10.1111/j.1471-0528.1992.tb13822.x. [DOI] [PubMed] [Google Scholar]
  140. Mori S., Wolfinbarger J. B., Miyazawa M., Bloom M. E. Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages. J Virol. 1991 Feb;65(2):952–956. doi: 10.1128/jvi.65.2.952-956.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Mortimer P. P., Luban N. L., Kelleher J. F., Cohen B. J. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet. 1983 Aug 27;2(8348):482–484. doi: 10.1016/s0140-6736(83)90512-3. [DOI] [PubMed] [Google Scholar]
  142. Muir K., Todd W. T., Watson W. H., Fitzsimons E. Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia. Lancet. 1992 May 9;339(8802):1139–1140. doi: 10.1016/0140-6736(92)90735-l. [DOI] [PubMed] [Google Scholar]
  143. Murai C., Munakata Y., Takahashi Y., Ishii T., Shibata S., Muryoi T., Funato T., Nakamura M., Sugamura K., Sasaki T. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis. 1999 Feb;58(2):130–132. doi: 10.1136/ard.58.2.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Muraoka O., Kaisho T., Tanabe M., Hirano T. Transcriptional activation of the interleukin-6 gene by HTLV-1 p40tax through an NF-kappa B-like binding site. Immunol Lett. 1993 Aug;37(2-3):159–165. doi: 10.1016/0165-2478(93)90026-x. [DOI] [PubMed] [Google Scholar]
  145. Nagahama Y., Shimohama S., Kaji R., Akiguchi I., Kimura J. [An adult case of transverse myelitis with erythema infectiosum]. Rinsho Shinkeigaku. 1992 Sep;32(9):1035–1037. [PubMed] [Google Scholar]
  146. Nagai K., Morohoshi T., Kudoh T., Yoto Y., Suzuki N., Matsunaga Y. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Haematol. 1992 Jan;80(1):131–132. doi: 10.1111/j.1365-2141.1992.tb06416.x. [DOI] [PubMed] [Google Scholar]
  147. Naides S. J., Howard E. J., Swack N. S., True C. A., Stapleton J. T. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis. 1993 Jul;168(1):101–105. doi: 10.1093/infdis/168.1.101. [DOI] [PubMed] [Google Scholar]
  148. Naides S. J., Piette W., Veach L. A., Argenyi Z. Human parvovirus B19-induced vesiculopustular skin eruption. Am J Med. 1988 May;84(5):968–972. doi: 10.1016/0002-9343(88)90081-2. [DOI] [PubMed] [Google Scholar]
  149. Naides S. J., Scharosch L. L., Foto F., Howard E. J. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum. 1990 Sep;33(9):1297–1309. doi: 10.1002/art.1780330901. [DOI] [PubMed] [Google Scholar]
  150. Naides S. J., Weiner C. P. Antenatal diagnosis and palliative treatment of non-immune hydrops fetalis secondary to fetal parvovirus B19 infection. Prenat Diagn. 1989 Feb;9(2):105–114. doi: 10.1002/pd.1970090205. [DOI] [PubMed] [Google Scholar]
  151. Nakajima T., Aono H., Hasunuma T., Yamamoto K., Maruyama I., Nosaka T., Hatanaka M., Nishioka K. Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. J Clin Invest. 1993 Jul;92(1):186–193. doi: 10.1172/JCI116548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Ndimbie O. K., Frezza E., Jordan J. A., Koch W., van Thiel D. H. Parvovirus B19 in anemic liver transplant recipients. Clin Diagn Lab Immunol. 1996 Nov;3(6):756–760. doi: 10.1128/cdli.3.6.756-760.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Nesher G., Osborn T. G., Moore T. L. Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum. 1995 Apr;24(5):297–303. doi: 10.1016/s0049-0172(95)80001-8. [DOI] [PubMed] [Google Scholar]
  154. Niitsu H., Takatsu H., Miura I., Chubachi A., Ito T., Hirokawa M., Endo Y., Miura A., Fukuda M., Sasaki T. [Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation]. Rinsho Ketsueki. 1990 Sep;31(9):1566–1571. [PubMed] [Google Scholar]
  155. Nikkari S., Luukkainen R., Möttönen T., Meurman O., Hannonen P., Skurnik M., Toivanen P. Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis. 1994 Feb;53(2):106–111. doi: 10.1136/ard.53.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Nikkari S., Roivainen A., Hannonen P., Möttönen T., Luukkainen R., Yli-Jama T., Toivanen P. Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis. 1995 Jul;54(7):597–600. doi: 10.1136/ard.54.7.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Nishioka K., Maruyama I., Sato K., Kitajima I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989 Feb 25;1(8635):441–441. doi: 10.1016/s0140-6736(89)90038-x. [DOI] [PubMed] [Google Scholar]
  158. Nocton J. J., Miller L. C., Tucker L. B., Schaller J. G. Human parvovirus B19-associated arthritis in children. J Pediatr. 1993 Feb;122(2):186–190. doi: 10.1016/s0022-3476(06)80111-3. [DOI] [PubMed] [Google Scholar]
  159. Okumura A., Ichikawa T. Aseptic meningitis caused by human parvovirus B19. Arch Dis Child. 1993 Jun;68(6):784–785. doi: 10.1136/adc.68.6.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Osaki M., Matsubara K., Iwasaki T., Kurata T., Nigami H., Harigaya H., Baba K. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol. 1999 Feb;78(2):83–86. doi: 10.1007/s002770050477. [DOI] [PubMed] [Google Scholar]
  161. Ozawa K., Ayub J., Kajigaya S., Shimada T., Young N. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol. 1988 Aug;62(8):2884–2889. doi: 10.1128/jvi.62.8.2884-2889.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Ozawa K., Kurtzman G., Young N. Replication of the B19 parvovirus in human bone marrow cell cultures. Science. 1986 Aug 22;233(4766):883–886. doi: 10.1126/science.3738514. [DOI] [PubMed] [Google Scholar]
  163. Ozawa K., Young N. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol. 1987 Aug;61(8):2627–2630. doi: 10.1128/jvi.61.8.2627-2630.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. 1981 Mar 21;1(8221):664–665. doi: 10.1016/s0140-6736(81)91579-8. [DOI] [PubMed] [Google Scholar]
  165. Plummer F. A., Hammond G. W., Forward K., Sekla L., Thompson L. M., Jones S. E., Kidd I. M., Anderson M. J. An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med. 1985 Jul 11;313(2):74–79. doi: 10.1056/NEJM198507113130203. [DOI] [PubMed] [Google Scholar]
  166. Pont J., Puchhammer-Stöckl E., Chott A., Popow-Kraupp T., Kienzer H., Postner G., Honetz N. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol. 1992 Feb;80(2):160–165. doi: 10.1111/j.1365-2141.1992.tb08894.x. [DOI] [PubMed] [Google Scholar]
  167. Porter D. D., Larsen A. E., Porter H. G. The pathogenesis of Aleutian disease of mink. 3. Immune complex arteritis. Am J Pathol. 1973 May;71(2):331–344. [PMC free article] [PubMed] [Google Scholar]
  168. Porter D. D., Larsen A. E., Porter H. G. The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med. 1969 Sep 1;130(3):575–593. doi: 10.1084/jem.130.3.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Potter C. G., Potter A. C., Hatton C. S., Chapel H. M., Anderson M. J., Pattison J. R., Tyrrell D. A., Higgins P. G., Willman J. S., Parry H. F. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest. 1987 May;79(5):1486–1492. doi: 10.1172/JCI112978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Pouchot J., Ouakil H., Debin M. L., Vinceneux P. Adult Still's disease associated with acute human parvovirus B19 infection. Lancet. 1993 May 15;341(8855):1280–1281. doi: 10.1016/0140-6736(93)91184-n. [DOI] [PubMed] [Google Scholar]
  171. Rao S. P., Miller S. T., Cohen B. J. Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission. Am J Pediatr Hematol Oncol. 1990 Summer;12(2):194–197. doi: 10.1097/00043426-199022000-00013. [DOI] [PubMed] [Google Scholar]
  172. Rechavi G., Vonsover A., Manor Y., Mileguir F., Shpilberg O., Kende G., Brok-Simoni F., Mandel M., Gotlieb-Stematski T., Ben-Bassat I. Aplastic crisis due to human B19 parvovirus infection in red cell pyrimidine-5'-nucleotidase deficiency. Acta Haematol. 1989;82(1):46–49. doi: 10.1159/000205278. [DOI] [PubMed] [Google Scholar]
  173. Reid D. M., Reid T. M., Brown T., Rennie J. A., Eastmond C. J. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. 1985 Feb 23;1(8426):422–425. doi: 10.1016/s0140-6736(85)91146-8. [DOI] [PubMed] [Google Scholar]
  174. Rosenfeld S. J., Yoshimoto K., Kajigaya S., Anderson S., Young N. S., Field A., Warrener P., Bansal G., Collett M. S. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest. 1992 Jun;89(6):2023–2029. doi: 10.1172/JCI115812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Rothschild B. M., Turner K. R., DeLuca M. A. Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama. Science. 1988 Sep 16;241(4872):1498–1501. doi: 10.1126/science.3047874. [DOI] [PubMed] [Google Scholar]
  176. Rothschild B. M., Woods R. J., Rothschild C., Sebes J. I. Geographic distribution of rheumatoid arthritis in ancient North America: implications for pathogenesis. Semin Arthritis Rheum. 1992 Dec;22(3):181–187. doi: 10.1016/0049-0172(92)90018-9. [DOI] [PubMed] [Google Scholar]
  177. Saal J. G., Steidle M., Einsele H., Müller C. A., Fritz P., Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int. 1992;12(4):147–151. doi: 10.1007/BF00274934. [DOI] [PubMed] [Google Scholar]
  178. Saarinen U. M., Chorba T. L., Tattersall P., Young N. S., Anderson L. J., Palmer E., Coccia P. F. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986 May;67(5):1411–1417. [PubMed] [Google Scholar]
  179. Saint-Martin J., Bonnaud E., Morinet F., Choulot J. J., Mensire A. Myocardite aiguë à parvovirus d'évolution létale. Pediatrie. 1991;46(8-9):597–599. [PubMed] [Google Scholar]
  180. Samii K., Cassinotti P., de Freudenreich J., Gallopin Y., Le Fort D., Stalder H. Acute bilateral carpal tunnel syndrome associated with human parvovirus B19 infection. Clin Infect Dis. 1996 Jan;22(1):162–164. doi: 10.1093/clinids/22.1.162. [DOI] [PubMed] [Google Scholar]
  181. Scala G., Ruocco M. R., Ambrosino C., Mallardo M., Giordano V., Baldassarre F., Dragonetti E., Quinto I., Venuta S. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med. 1994 Mar 1;179(3):961–971. doi: 10.1084/jem.179.3.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Schwarz T. F., Roggendorf M., Suschke H., Deinhardt F. Human parvovirus B19 infection and juvenile chronic polyarthritis. Infection. 1987 Jul-Aug;15(4):264–265. doi: 10.1007/BF01644133. [DOI] [PubMed] [Google Scholar]
  183. Schwarz T. F., Serke S., Hottenträger B., von Brunn A., Baurmann H., Kirsch A., Stolz W., Huhn D., Deinhardt F., Roggendorf M. Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol. 1992 Feb;66(2):1273–1276. doi: 10.1128/jvi.66.2.1273-1276.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Schwarz T. F., Wiersbitzky S., Pambor M. Case report: detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol. 1994 Jun;43(2):171–174. doi: 10.1002/jmv.1890430214. [DOI] [PubMed] [Google Scholar]
  185. Sekine T., Kato T., Masuko-Hongo K., Nakamura H., Yoshino S., Nishioka K., Yamamoto K. Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis. 1999 Jul;58(7):446–450. doi: 10.1136/ard.58.7.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Serke S., Schwarz T. F., Baurmann H., Kirsch A., Hottenträger B., Von Brunn A., Roggendorf M., Huhn D., Deinhardt F. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization. Br J Haematol. 1991 Sep;79(1):6–13. doi: 10.1111/j.1365-2141.1991.tb07999.x. [DOI] [PubMed] [Google Scholar]
  187. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986 Jun;58(3):921–936. doi: 10.1128/jvi.58.3.921-936.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Shimizu Y., Ueno T., Komatsu H., Takada H., Nunoue T. Acute cerebellar ataxia with human parvovirus B19 infection. Arch Dis Child. 1999 Jan;80(1):72–73. doi: 10.1136/adc.80.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Shiraishi H., Umetsu K., Yamamoto H., Hatakeyama Y., Yaegashi N., Sugamura K. Human parvovirus (HPV/B19) infection with purpura. Microbiol Immunol. 1989;33(4):369–372. doi: 10.1111/j.1348-0421.1989.tb01984.x. [DOI] [PubMed] [Google Scholar]
  190. Shirono K., Tsuda H. Parvovirus B19-associated haemophagocytic syndrome in healthy adults. Br J Haematol. 1995 Apr;89(4):923–926. doi: 10.1111/j.1365-2141.1995.tb08440.x. [DOI] [PubMed] [Google Scholar]
  191. Short C. L. The antiquity of rheumatoid arthritis. Arthritis Rheum. 1974 May-Jun;17(3):193–205. doi: 10.1002/art.1780170302. [DOI] [PubMed] [Google Scholar]
  192. Simpson R. W., McGinty L., Simon L., Smith C. A., Godzeski C. W., Boyd R. J. Association of parvoviruses with rheumatoid arthritis of humans. Science. 1984 Mar 30;223(4643):1425–1428. doi: 10.1126/science.6701529. [DOI] [PubMed] [Google Scholar]
  193. Sokal E. M., Melchior M., Cornu C., Vandenbroucke A. T., Buts J. P., Cohen B. J., Burtonboy G. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet. 1998 Nov 28;352(9142):1739–1741. doi: 10.1016/S0140-6736(98)06165-0. [DOI] [PubMed] [Google Scholar]
  194. Sol N., Le Junter J., Vassias I., Freyssinier J. M., Thomas A., Prigent A. F., Rudkin B. B., Fichelson S., Morinet F. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol. 1999 Oct;73(10):8762–8770. doi: 10.1128/jvi.73.10.8762-8770.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Sosa C. E., Mahony J. B., Luinstra K. E., Sternbach M., Chernesky M. A. Replication and cytopathology of human parvovirus B19 in human umbilical cord blood erythroid progenitor cells. J Med Virol. 1992 Feb;36(2):125–130. doi: 10.1002/jmv.1890360209. [DOI] [PubMed] [Google Scholar]
  196. Speyer I., Breedveld F. C., Dijkmans B. A. Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin Exp Rheumatol. 1998 Sep-Oct;16(5):576–578. [PubMed] [Google Scholar]
  197. Srivastava A., Lu L. Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol. 1988 Aug;62(8):3059–3063. doi: 10.1128/jvi.62.8.3059-3063.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Srivastava C. H., Zhou S., Munshi N. C., Srivastava A. Parvovirus B19 replication in human umbilical cord blood cells. Virology. 1992 Aug;189(2):456–461. doi: 10.1016/0042-6822(92)90569-b. [DOI] [PubMed] [Google Scholar]
  199. Stringer M. D., Melissari E., Kakkar V. V., Tan K. C. Protein C deficiency and thrombotic complications after liver transplantation in children. Lancet. 1989 Jan 14;1(8629):102–103. doi: 10.1016/s0140-6736(89)91459-1. [DOI] [PubMed] [Google Scholar]
  200. Stults C. L., Sweeley C. C., Macher B. A. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol. 1989;179:167–214. doi: 10.1016/0076-6879(89)79122-9. [DOI] [PubMed] [Google Scholar]
  201. Summers J., Jones S. E., Anderson M. J. Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. J Gen Virol. 1983 Nov;64(Pt 11):2527–2532. doi: 10.1099/0022-1317-64-11-2527. [DOI] [PubMed] [Google Scholar]
  202. Söderlund M., von Essen R., Haapasaari J., Kiistala U., Kiviluoto O., Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet. 1997 Apr 12;349(9058):1063–1065. doi: 10.1016/S0140-6736(96)09110-6. [DOI] [PubMed] [Google Scholar]
  203. Takahashi T., Ozawa K., Mitani K., Miyazono K., Asano S., Takaku F. B19 parvovirus replicates in erythroid leukemic cells in vitro. J Infect Dis. 1989 Sep;160(3):548–549. doi: 10.1093/infdis/160.3.548. [DOI] [PubMed] [Google Scholar]
  204. Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., Saitoh T., Sawai T., Sugamura K., Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8227–8232. doi: 10.1073/pnas.95.14.8227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Tanaka A., Sugawara A., Sawai K., Kuwahara T. Human parvovirus B19 infection resembling systemic lupus erythematosus. Intern Med. 1998 Aug;37(8):708–710. doi: 10.2169/internalmedicine.37.708. [DOI] [PubMed] [Google Scholar]
  206. Taylor H. G., Borg A. A., Dawes P. T. Human parvovirus B19 and rheumatoid arthritis. Clin Rheumatol. 1992 Dec;11(4):548–550. doi: 10.1007/BF02283117. [DOI] [PubMed] [Google Scholar]
  207. Tiessen R. G., van Elsacker-Niele A. M., Vermeij-Keers C., Oepkes D., van Roosmalen J., Gorsira M. C. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn. 1994 Mar;14(3):173–176. doi: 10.1002/pd.1970140305. [DOI] [PubMed] [Google Scholar]
  208. Trapani S., Ermini M., Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum. 1999 Apr;28(5):319–325. doi: 10.1016/s0049-0172(99)80016-x. [DOI] [PubMed] [Google Scholar]
  209. Tsuda H. Liver dysfunction caused by parvovirus B19. Am J Gastroenterol. 1993 Sep;88(9):1463–1463. [PubMed] [Google Scholar]
  210. Tsukada T., Koike T., Koike R., Sanada M., Takahashi M., Shibata A., Nunoue T. Epidemic of aplastic crisis in patients with hereditary spherocytosis in Japan. Lancet. 1985 Jun 15;1(8442):1401–1401. doi: 10.1016/s0140-6736(85)91836-7. [DOI] [PubMed] [Google Scholar]
  211. Tyndall A., Jelk W., Hirsch H. H. Parvovirus B19 and erosive polyarthritis. Lancet. 1994 Feb 19;343(8895):480–481. doi: 10.1016/s0140-6736(94)92725-1. [DOI] [PubMed] [Google Scholar]
  212. Umene K., Nunoue T. A new genome type of human parvovirus B19 present in sera of patients with encephalopathy. J Gen Virol. 1995 Nov;76(Pt 11):2645–2651. doi: 10.1099/0022-1317-76-11-2645. [DOI] [PubMed] [Google Scholar]
  213. Vigeant P., Ménard H. A., Boire G. Chronic modulation of the autoimmune response following parvovirus B19 infection. J Rheumatol. 1994 Jun;21(6):1165–1167. [PubMed] [Google Scholar]
  214. Wada Y., Kobayashi M., Kubo M. [A girl with systemic onset juvenile rheumatoid arthritis suspected to be due to human parvovirus B19 infection]. Kansenshogaku Zasshi. 1997 May;71(5):468–473. doi: 10.11150/kansenshogakuzasshi1970.71.468. [DOI] [PubMed] [Google Scholar]
  215. Wagner A. D., Goronzy J. J., Matteson E. L., Weyand C. M. Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection. Mayo Clin Proc. 1995 Mar;70(3):261–265. doi: 10.4065/70.3.261. [DOI] [PubMed] [Google Scholar]
  216. Walsh K. J., Armstrong R. D., Turner A. M. Brachial plexus neuropathy associated with human parvovirus infection. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):896–896. doi: 10.1136/bmj.296.6626.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Watanabe M., Shimamoto Y., Yamaguchi M., Inada S., Miyazaki S., Sato H. Viral-associated haemophagocytosis and elevated serum TNF-alpha with parvovirus-B19-related pancytopenia in patients with hereditary spherocytosis. Clin Lab Haematol. 1994 Jun;16(2):179–182. doi: 10.1111/j.1365-2257.1994.tb00404.x. [DOI] [PubMed] [Google Scholar]
  218. Watanabe T., Satoh M., Oda Y. Human parvovirus B19 encephalopathy. Arch Dis Child. 1994 Jan;70(1):71–71. doi: 10.1136/adc.70.1.71-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  219. Weiland H. T., Vermey-Keers C., Salimans M. M., Fleuren G. J., Verwey R. A., Anderson M. J. Parvovirus B19 associated with fetal abnormality. Lancet. 1987 Mar 21;1(8534):682–683. doi: 10.1016/s0140-6736(87)90442-9. [DOI] [PubMed] [Google Scholar]
  220. West N. C., Meigh R. E., Mackie M., Anderson M. J. Parvovirus infection associated with aplastic crisis in a patient with HEMPAS. J Clin Pathol. 1986 Sep;39(9):1019–1020. doi: 10.1136/jcp.39.9.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  221. White D. G., Woolf A. D., Mortimer P. P., Cohen B. J., Blake D. R., Bacon P. A. Human parvovirus arthropathy. Lancet. 1985 Feb 23;1(8426):419–421. doi: 10.1016/s0140-6736(85)91145-6. [DOI] [PubMed] [Google Scholar]
  222. Woolf A. D., Campion G. V., Chishick A., Wise S., Cohen B. J., Klouda P. T., Caul O., Dieppe P. A. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989 May;149(5):1153–1156. [PubMed] [Google Scholar]
  223. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., Sugamura K. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol. 1989 Jun;63(6):2422–2426. doi: 10.1128/jvi.63.6.2422-2426.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  224. Yoto Y., Kudoh T., Asanuma H., Numazaki K., Tsutsumi Y., Nakata S., Chiba S. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet. 1994 Aug 27;344(8922):624–625. [PubMed] [Google Scholar]
  225. Young N. S., Mortimer P. P., Moore J. G., Humphries R. K. Characterization of a virus that causes transient aplastic crisis. J Clin Invest. 1984 Jan;73(1):224–230. doi: 10.1172/JCI111195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. de Benedetti F., Massa M., Robbioni P., Ravelli A., Burgio G. R., Martini A. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1991 Sep;34(9):1158–1163. doi: 10.1002/art.1780340912. [DOI] [PubMed] [Google Scholar]
  227. van Elsacker-Niele A. M., Weiland H. T., Kroes A. C., Kappers-Klunne M. C. Parvovirus B19 infection and idiopathic thrombocytopenic purpura. Ann Hematol. 1996 Mar;72(3):141–144. doi: 10.1007/s002770050152. [DOI] [PubMed] [Google Scholar]
  228. von Poblotzki A., Gerdes C., Reischl U., Wolf H., Modrow S. Lymphoproliferative responses after infection with human parvovirus B19. J Virol. 1996 Oct;70(10):7327–7330. doi: 10.1128/jvi.70.10.7327-7330.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. von Poblotzki A., Gigler A., Lang B., Wolf H., Modrow S. Antibodies to parvovirus B19 NS-1 protein in infected individuals. J Gen Virol. 1995 Mar;76(Pt 3):519–527. doi: 10.1099/0022-1317-76-3-519. [DOI] [PubMed] [Google Scholar]
  230. von Poblotzki A., Hemauer A., Gigler A., Puchhammer-Stöckl E., Heinz F. X., Pont J., Laczika K., Wolf H., Modrow S. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J Infect Dis. 1995 Nov;172(5):1356–1359. doi: 10.1093/infdis/172.5.1356. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES